Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Longer Exclusivity Periods For EU Centralized Rx-To-OTC Switches? Commission Says No

May 25 2023

• By David Ridley

Rejected

Related Content

EMA Recommends EU-Wide Desloratadine Switch

Oct 19 2020

Fortacin Wins Commission Approval As Fifth EU-Wide Rx-To-OTC Switch

Sep 08 2020

EMA’s Frias Defends EU Centralized Switch Procedure Despite Only Delivering Four Reclassifications In 10 Years

Mar 26 2019

AESGP Annual Meeting: OTC Antifungals, Antivirals Could Become Rx In EU

May 24 2023

Related Companies

Haleon plc

Recordati SpA

Bayer Consumer Care

Additional Topics

Europe Advisory Committees Business Strategies EU Legislative Reform Innovation Legislation Lobbying Market Access Market Intelligence NGOs OTC Drugs Prescription To OTC Switch Real-World Evidence Regulation Research & Development Strategy Consumer

More from Europe

More from Geography

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window